One consequence of allogenic hematopoietic stem cell transplantation (HSCT) is the development of a chronic graft-versus-host disease where the patients who developed GVHD had decreased levels of Treg/Tconv (CD4) and Treg:CD8 ratios indicating an unfavorable regulatory scenario [52]. Here, CD4 is linked to graft versus host disease.